← Back to Clinical Trials
Recruiting NCT02420470

The Early Warning System for the Diabetic Encephalopathy

Trial Parameters

Condition Diabetes Mellitus Type 2
Sponsor Tang-Du Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 40 Years
Max Age 65 Years
Start Date 2015-04
Completion 2025-11

Brief Summary

Diabetes( mainly type II diabetes )lead to the central nervous system (CNS) function impairment, especially the mild cognitive impairment that increased the risk of progression to dementia.The primary objectives are defined according to a hierarchical design: i) to tailor and apply multi-parametric, functional MRI techniques to identify cerebral abnormalities (cerebral biomarkers) in type 2 diabetes mellitus and prodromal diabetes mellitus ; ii) to assess whether these cerebral biomarkers are associated with cognitive decrements;iii) to follow up with the putative prediabetic condition patients to verify whether they can transform into diabetes.

Eligibility Criteria

Inclusion Criteria: * without dementia * Inform Consent Form * Education time more than 6 years * blood glucose matches the group standard Exclusion Criteria: * Pregnant woman * suffer from serious brain disease * Magnetic resonance contraindications * lack of compliance * image quality is too poor to deal with

Related Trials